Sex And Survival: In Some Matters Of The Heart Women Have The Edge

April 13, 1999

DALLAS, April 13 -- Women with advanced congestive heart failure (CHF) live twice as long as their male counterparts, according to a study in today's Circulation: Journal of the American Heart Association.

Lead researcher Kirkwood F. Adams Jr., M.D., at the University of North Carolina (UNC), Chapel Hill, says that a woman has a survival advantage even if her CHF is as severe as a man's and she has had the disease for the same duration.

The study is significant because it challenges previous research findings suggesting that the survival advantage of women with heart failure over that of men might be due to differences between men and women in the type of treatment they received and the length of time they had the disease.

The only form of cardiovascular disease that is increasing dramatically in the population is congestive heart failure, a condition in which the heart cannot pump enough blood to meet the demands of the body. An estimated 4.6 million Americans have CHF.

"Our analysis also suggests that the trend for increased survival is strongest among a subset of patients --- those with CHF that is not due to ischemia, or lack of blood supply to the heart," says Adams.

Ischemic heart disease results from atherosclerosis caused by fat-laden plaque obstructions that develop in blood vessels. Nonischemic heart failure results from high blood pressure or other factors that can weaken the heart muscle.

Adams' study used data from the Flolan International Randomized Survival Trial (FIRST), which included 359 men and 112 women with "end-stage," or class IV, heart failure. After eliminating patients for whom baseline characteristics were not available, survival data on 331 men and 99 women were compared.

Researchers compared groups that were similar in characteristics such as age, gender, race, weight, diabetes, duration of heart failure and high blood pressure. Other characteristics included the distance the patients walked in six minutes and dobutamine (Dobutrex) use -- a drug used to increase the heart's blood output in patients with CHF.

The study found other differences between the men and women with CHF. Men with CHF were more likely than females to be Caucasian, to have atherosclerosis as the primary cause of their condition, to have less severe CHF, and less dobutamine use.

Men with nonischemic heart disease were three times more likely than females to die during the first year-and-a-half follow-up period. Men with ischemic heart disease were about one-and-one-half times more likely to die during that period. Overall, males whose CHF was caused by high blood pressure and other factors were twice as likely to die as their female counterparts. "These are impressive differences," says Adams, associate professor of medicine and radiology and director of UNC's Heart Failure Program.

"There are several unique aspects of the FIRST study population which enhance the likelihood that biological differences are an important cause of the survival difference we observed between males and females," Adams says. "A growing body of evidence points to fundamental gender-related differences in the nature and extent of heart failure."

However, the researchers cautioned that larger studies are needed to further explore mechanisms of differences in survival rates between the sexes.

Other researchers included Carla A. Sueta, Ph.D., Todd A. Schwartz, and Gary G. Koch, Ph.D., also of University of North Carolina; Mihai Gheorghiade, M.D., Northwestern University Medical School; Christopher M. O'Connor, M.D., and Robert M. Califf, M.D., Duke University Medical Center; Barry Uretsky, M.D., University of Texas Medical Branch at Galveston; Karl Swedberg, M.D., Ostra University Hospital; William McKenna, M.D., St. George's Hospital Medical School; and Jordi Soler-Soler, M.D., Hospital Universitari Vall D'Hebron in Barcelona.
-end-
Media advisory: Dr. Adams can be reached by calling 919-966-4445. (Please do not publish telephone numbers.)



American Heart Association

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.